DUBLIN–(BUSINESS WIRE)–The “Cell Therapy Market Research Report by Cell Type (Differentiated Cell and Stem Cell), Therapy Type, Application, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.
The Global Cell Therapy Market size was estimated at USD 5,458.66 million in 2021, USD 6,040.14 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.82% to reach USD 10,116.16 million by 2027.
In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.
Cumulative Impact of COVID-19:
The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.
It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Automotive Windshield Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space.
It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles:
- Anterogen Co.,Ltd.
- Astellas Pharma Inc.
- Castle Creek Biosciences, Inc.
- Celgene Corporation
- FUJIFILM Holdings America Corporation
- JCR Pharmaceuticals Co., Ltd.
- Lonza Group AG
- Medipost Co., Ltd.
- Novartis AG
- NuVasive, Inc
- Pfizer Inc.
- PHARMICELL Co., Ltd.
- Sartorius AG
- Smith & Nephew PLC
- Stemedica Cell Technologies, Inc.
- Takeda Pharmaceutical Company Limited
- Thermo Fisher Scientific Inc.
- Vericel Corporation
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing use of stem cell for treatment of Alzheimer’s disease
5.1.1.2. Improvements in cell therapy supply chain
5.1.1.3. Increasing cell research activities and increasing approvals
5.1.2. Restraints
5.1.2.1. Side effects related to the stem cell transplant
5.1.3. Opportunities
5.1.3.1. Advancements in chimeric antigen receptor T-cell (CAR-T) therapies for cancer treatments
5.1.3.2. Investment help fuel a surge in biotech innovation
5.1.3.3. Use of ESCs (embryonic stem cells) and iPSCs (Induced pluripotent stem cells) to replace lost retinal cells
5.1.4. Challenges
5.1.4.1. Several ethical issues associated with the use of stem cells
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Cell Therapy Market, by Cell Type
6.1. Introduction
6.2. Differentiated Cell
6.3. Stem Cell
7. Cell Therapy Market, by Therapy Type
7.1. Introduction
7.2. Allogenic Therapies
7.3. Autologous Therapies
8. Cell Therapy Market, by Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Dermatology
8.4. Muscoskeletal Therapies
8.5. Oncology
9. Cell Therapy Market, by End-User
9.1. Introduction
9.2. Biotechnology and Pharmaceutical Companies
9.3. Hospitals and Clinics
9.4. Research Institutes
10. Americas Cell Therapy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Therapy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Cell Therapy Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
For more information about this report visit https://www.researchandmarkets.com/r/gwl71x
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900